Page 1 of Clinical Trials for International Breast Cancer Study Group [SPONSOR-COLLABORATORS], 25 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Active, not recruiting
Suppression of Ovarian Function Plus Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
Last Updated: February 8, 2012
Condition(s): Breast Cancer
2
Active, not recruiting
Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
Last Updated: February 8, 2012
Condition(s): Breast Cancer
3
Recruiting
Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast Cancer
Last Updated: March 2, 2012
Condition(s): Breast Cancer
4
Recruiting
Study of Changes in Estrogen Levels and Grip Strength in Postmenopausal Women Who Have Received 4 to 6 Years of Hormone Therapy for Breast Cancer and Are Currently Receiving Letrozole on Clinical Trial IBCSG-35-07
Last Updated: March 2, 2012
Condition(s): Breast Cancer
5
Active, not recruiting
Surgical Resection With or Without Axillary Lymph Node Dissection in Treating Women With Node-Negative Breast Cancer and Sentinel Lymph Node Micrometastases
Last Updated: February 14, 2012
Condition(s): Breast Cancer
6
Completed
Suppression of Ovarian Function and Either Tamoxifen or Exemestane With or Without Chemotherapy in Treating Premenopausal Women With Resected Breast Cancer
Last Updated: February 6, 2009
Condition(s): Breast Cancer
7
Active, not recruiting
Study of Bone Mineral Density in Women With Breast Cancer Treated With Triptorelin and Tamoxifen or Exemestane on Protocol IBC SG-25-02 (TEXT)
Last Updated: March 8, 2011
Condition(s): Breast Cancer; Osteoporosis
8
Active, not recruiting
Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG-2402
Last Updated: March 1, 2011
Condition(s): Breast Cancer; Cognitive/Functional Effects; Fatigue; Psychosocial Effects of Cancer and Its Treatment; Sleep Disorders
9
Active, not recruiting
Letrozole or Tamoxifen in Treating Postmenopausal Women With Breast Cancer
Last Updated: November 17, 2011
Condition(s): Breast Cancer
10
Active, not recruiting
Adjuvant Chemotherapy in Treating Women Who Have Undergone Resection for Relapsed Breast Cancer
Last Updated: February 4, 2010
Condition(s): Breast Cancer
11
Active, not recruiting
Liposomal Doxorubicin Compared With Observation or Cyclophosphamide and Methotrexate in Treating Older Women Who Have Undergone Surgery for Breast Cancer
Last Updated: February 6, 2009
Condition(s): Breast Cancer
12
Recruiting
Risedronate in Improving Bone Mineral Density and Bone Health in Postmenopausal Women With Ductal Carcinoma In Situ Enrolled in Clinical Trial CRUK-IBIS-II-DCIS
Last Updated: June 15, 2011
Condition(s): Breast Cancer; Osteoporosis
13
Recruiting
Combination Chemotherapy After Surgery in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer
Last Updated: August 5, 2011
Condition(s): Breast Cancer
14
Active, not recruiting
Cognitive Function in Postmenopausal Women With Breast Cancer Receiving Hormone Therapy on Clinical Trial IBCSG-1-98
Last Updated: July 20, 2009
Condition(s): Breast Cancer; Cognitive/Functional Effects; Fatigue; Psychosocial Effects of Cancer and Its Treatment
15
Active, not recruiting
Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I or Stage IIA Breast Cancer
Last Updated: February 6, 2009
Condition(s): Breast Cancer
16
Active, not recruiting
Hormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal Women With Node-Positive Breast Cancer
Last Updated: February 11, 2010
Condition(s): Breast Cancer
17
Active, not recruiting
Bone Density and Bone Loss in Postmenopausal Women With Breast Cancer Receiving Treatment in Clinical Trial IBCSG-1-98
Last Updated: May 9, 2009
Condition(s): Breast Cancer; Osteoporosis
18
Active, not recruiting
Study of Estrogen Levels in Premenopausal Women Who Have Undergone Surgery for Breast Cancer and Are Receiving Triptorelin and Tamoxifen Citrate or Exemestane on Clinical Trial IBCSG-2402
Last Updated: March 5, 2011
Condition(s): Breast Cancer
19
Active, not recruiting
High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Combination Chemotherapy in Treating Women With High-Risk Breast Cancer
Last Updated: June 10, 2009
Condition(s): Breast Cancer
20
Active, not recruiting
Fingernails in Evaluating Bone Health in Postmenopausal Women With Breast Cancer Undergoing Hormone Therapy on Clinical Trial IBCSG-1-98
Last Updated: May 16, 2009
Condition(s): Breast Cancer; Osteoporosis

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=International+Breast+Cancer+Study+Group

Page 1 of Clinical Trials for International Breast Cancer Study Group [SPONSOR-COLLABORATORS], 25 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About